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It is well-established that psychotherapies can effect-
ively treat depression. In the past four decades, more
than 400 randomized controlled trials have been con-
ducted (Cuijpers, 2015), showing that different types
of psychotherapy are effective (Barth et al. 2013), that
the effects do not or only marginally differ from each
other, that they are comparable with those of antide-
pressants, and that combined treatment is more effect-
ive than psychotherapy or medication alone (Cuijpers,
2014). However, psychotherapies are probably less
effective in chronic depression and dysthymia, when
patients have comorbid alcohol problems, and in sub-
threshold depression, although in these patients ther-
apies can prevent the onset of full-blown major
depressive disorders (Cuijpers et al. 2014).
The two Editorials in this issue give interesting per-
spectives onwherewearewith researchon these therap-
ies andwhat should happen in the future (Hollon, 2015;
Solomonov & Barber, 2015). The first thing that stands
out is that both agree that although psychotherapies
are effective, there is still considerable room for
improvement. The Editorials point at the problem that
the effects of psychotherapy have been overestimated
because of publication bias, but also that the longer
term effects of psychotherapies are not well known,
except maybe for cognitive-behavioural therapy where
longer-term effects have been shown (Karyotaki et al.
2014) in several trials. The small effects of psychothera-
pies and treatments in general in chronic and
treatment-resistant depression (Cuijpers et al. 2010d)
and the high relapse rates after successful recovery
(Vittengl et al. 2007) are also important problems.
I want to underscore that although therapies are
effective, there is still much room for improvement.
The effect sizes found for treatments for mental disor-
ders do not differ very much from those in general
medical disorders (Leucht et al. 2012), but still it is esti-
mated that current treatments cannot take away more
than one-third of the disease burden of depression,
and then only in optimal conditions (Andrews et al.
2004). And then there is the problem that more than
40% of the patients do not or only partially respond
to treatment and less than one-third of the patients
are completely recovered after treatment (Hollon
et al. 2002). And after successful response the relapse
rates are estimated to be 50% after 2 years and up
to 80% after 5 years (Vittengl et al. 2007). These pro-
blems are in addition to the problem that much of
the earlier research has considerably overestimated
the effects of acute treatments of depression, not only
because of publication bias, but also because of the
low quality of many trials in the field (Cuijpers et al.
2010c) and probably researcher allegiance (Munder
et al. 2013).
Both articles give indications for how future
research can contribute to a further reduction of the
disease burden. In addition to that, however, I would
like to stress that there is also much research that is
not needed anymore in the future. In the broader bio-
medical field it is estimated that about 85% of research
is wasted, because of irrelevant questions, inappropri-
ate designs and methods, and biased reporting
(Chalmers & Glasziou, 2009). There is no reason to
assume that this is very different in randomised trials
of psychotherapies for depression. We found earlier
that of 115 trials in this field only 11 met all nine gen-
erally accepted quality criteria, and that the effects of
these 11 studies were considerably smaller than those
of lower-quality studies (Cuijpers et al. 2010c). We
also found that adjusting for unpublished trials
reduces the effect size of psychotherapies with more
than one-third (Cuijpers et al. 2010b), and reporting
in these trials also is often biased (Flint et al. 2014).
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In addition to that, a considerable number of studies
report on the effects of newly developed psychothera-
pies for depression (e.g., Bédard et al. 2014; Giosan
et al. 2014) and on comparative trials comparing two
types of psychotherapies. It is well-established, how-
ever, that all therapies for depression are about equally
effective (Barth et al. 2013) and that if a new therapy
would indeed be more effective than an existing ther-
apy, it would take a new trial with about 800 patients
to show its superiority (Cuijpers & van Straten, 2011).
If a therapy is found to be superior to an existing ther-
apy in an underpowered trial that would rather raise
doubts about the validity of the trial than trust that
this new therapy is indeed more effective.
Other trials have focused on examining psy-
chotherapies for depression in specific target popula-
tions, like older adults, women with postpartum
depression and patients with comorbid general medic-
al disorders. However, meta-analyses consistently
show that psychotherapies are effective in all such tar-
get groups (Cuijpers et al. 2008). By far the majority of
trials examining psychotherapies for depression find
positive effects, whether these are in specific target
groups or in unselected populations of adults. It
seems therefore not necessary to spend resources on
examining these therapies in all such specific target
groups.
In the same way it can be argued that it is no longer
needed to examine different treatment formats in ran-
domised controlled, because all research consistently
suggests that individual, group, guided self-help and
guided Internet-based therapies formats result in com-
parable outcomes (Cuijpers et al. 2010a; Andersson
et al. 2014).
In order to reduce the disease burden of depression
much research is needed in many areas. The two arti-
cles give several directions for future directions in
research on psychological treatments, including
research how to reduce drop-out rates for psychothera-
pies, because they use considerable resources with
apparently little benefits (Solomonov & Barber, 2015).
But also more research on the long-term effects of
therapies, treatment-resistant and chronic depression,
the high relapse rates and more knowledge on who
benefits from which treatment are important goals
for future research, as justly indicated in these two
articles in this issue.
In this context it could be added that it is also
important to examine how treatments work, because
if we understand the processes of how therapies
work we may finally start improving the effects of
therapies. However, examining working mechanisms
of treatments is notoriously complicated (Kazdin,
2007), and requires different types of research, includ-
ing not only research on mediators in randomised
trials, but also experimental studies, theoretical work
and animal studies. Although this will require quite
some resources, it will be one of the few ways how
we can improve the effects of treatments. It has been
shown that all pharmacological therapies are about
equally effective, that all psychological treatments are
equally effective, and that pharmacological and psy-
chological treatments are also equally effective. That
means that all treatments we have are about equally
effective, while we hardly know anything about who
benefits from which treatment. This basically implies
that the effects of treatments have not been improved
since the 1950s when the tricyclic antidepressants
(TCAs) were first tested.
The other approach to a further reduction of the dis-
ease burden of depression is to focus on improvement
of how to apply treatments better in routine care and
how to scale treatment up. Although the effects of
treatments may not have improved since their first
development, mental health care has made consider-
able progress in terms of reaching depressed patients
and applying therapies to people who can benefit
from therapies. That is important because large
group of patients who may benefit from treatment
still do not use these services enough, like adolescents,
older adults, minority and lower socioeconomic
groups. And in low- and middle income countries
treatments are hardly available at all. It is important
therefore to simplify therapies and make them more
accessible.
The suggestion by Solomonov and Barber to
develop stepwise treatment models offers therefore
an interesting perspective, with the simplest and
cheapest treatments first, followed by more compli-
cated and intensive therapies. That is in line with
more generic models that are aimed at improving
existing treatments and making them more efficient,
like stepped care (van Straten et al. 2015) and collabora-
tive care models (Coventry et al. 2014). But there are
also other ways to improve access and simplify treat-
ments without reducing their effects, like using trained
lay health counsellors for the delivery of treatments in
low-resourced countries, as has been done in India
(Patel et al. 2010), or using Internet-based guided self-
help therapies which cost much less time than trad-
itional, individual therapies (Andersson & Cuijpers,
2009).
Psychotherapies and other treatments for adult
depression are effective, but there is also much room
for improvement. The two Editorials in this issue
give a nice overview of where we are and where we
should be heading. We need much research, on the
long-term effects, on treatments of chronic and
treatment-resistant depression, on relapse, and on
working mechanisms. But there is also much research
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which we no longer need because it has been examined
sufficiently, like new therapies that promise superior
effects over existing therapies while they always show
equal effects. Resources are scarce and using them for
unnecessary research will slow down progress and let
patients with depression suffer more than needed.
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